Treatment of TNNT1-Myopathy With L-Tyrosine.

Last updated: January 13, 2014
Sponsor: Hadassah Medical Organization
Overall Status: Trial Status Unknown

Phase

2

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT02035501
SimonEdvardson1
  • Ages < 20
  • All Genders

Study Summary

The purpose of the study is to investigate if treatment with L-Tyrosine improves selected outcome measures of TNNT1 myopathy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Male or female patients

  • any age with TNNT1-related myopathy

Exclusion

Exclusion Criteria:

  • Patients who are non-cooperative or parents/ legal guardians who are unwilling to signconsent form

Study Design

Total Participants: 10
Study Start date:
January 01, 2014
Estimated Completion Date:

Connect with a study center

  • Hadassah Medical Organization, Jerusalem, Israel

    Jerusalem,
    Israel

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.